a theranostic solution for chronic wounds
Medical sciences are one of the driving forces for future innovations improving both human welfare and efficiency. Our core values are innovativeness and accessibility towards safe and efficient therapies. We follow a theranostic approach for our product platform, i.e. We have built a comprehensive approach to the treatment of chronic wounds including: smart application for wound documentation, rapid biofilm diagnostics and wound maintenance and infection prevention and treatment.
Once infected, most wounds have an 85% chance to develop into a chronic wound (which means that it will not heal within three months).
Chronic wounds are associated with high direct and indirect costs. To date, no solutions exist that can effectively heal a chronic wound, as fast as we can. This is due to the fact that the protective layer of bacteria and biofilm in chronic wounds is extremely difficult to break down.
What if we could reach granulation in just a couple of weeks? What if we could do this in a simple 2 minutes procedure, without the need of performing maintenance debridements procedures. What if we would help drop the cost burden by 90%. What if we could share our experience on hundreds of patients.
What if you join us at the upcoming WUWHS 2020? We will be providing answers to all those questions.
QUALITY & SAFETY
We will fulfill the FDA 21 CFR 820 Quality System Regulations (QSR)
Patient safety allows no shortcuts, we respect the standards of our industry, and we trust all our partners to act in the same manner.
Read more about our latest publications and news items.
Chamber of Commerce : 74732706
DEBx Medical BV
George Gershwinlaan 241
Gustav Mahlerplein 28